Enjoy complimentary customisation on priority with our Enterprise License!
The intravenous (IV) solutions market size is estimated to grow at a CAGR of 7.11% between 2022 and 2027. The market size is forecast to increase by USD 4,011.34 million. The growth of the intravenous solutions market depends on several factors, including the increasing prevalence of chronic diseases, the growing geriatric population, and the increasing demand for parenteral nutrition.
This intravenous solutions market report extensively covers market segmentation by type (partial parenteral nutrition and total parenteral nutrition), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and geography (Asia, North America, Europe, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing prevalence of chronic diseases is notably driving the Intravenous (IV) Solutions Market growth. The market is growing rapidly due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. IV solutions are used to treat a variety of medical conditions and are critical for delivering fluids, electrolytes, and medications to patients. According to the International Diabetes Federation (IDF), the number of people with diabetes is expected to reach 700 million by 2045. Diabetic patients require intravenous solutions for glucose control, and the increasing prevalence of diabetes is expected to increase the demand for intravenous solutions during the forecast period.
In addition, the increasing number of cancer cases is also boosting the growth of the market. Cancer patients often require intravenous solutions to manage chemotherapy side effects such as dehydration and electrolyte imbalance. According to the American Cancer Society, the number of cancer cases worldwide is expected to reach 28.4 million by 2040, which should further increase the demand for IV solutions. Hence, the increasing prevalence of chronic diseases is expected to boost the growth of the market during the forecast period.
Technological advancements in IV solutions are a key trend influencing the IV Solutions Market growth. IV solutions are used to deliver medicines, fluids, and nutrients directly into the bloodstream and are an important part of modern medical practice. The latest technological advancements in IV solutions have improved their efficiency, safety, and effectiveness, thereby driving the market. One of the recent technological advances in the IV solutions market is the development of intelligent IV pumps. Intelligent IV pumps are designed to improve patient safety and reduce the risk of medication errors by automatically adjusting infusion rates based on patient weight, age, and medical condition.
Another technological advancement in the market is the development of closed system transfer devices (CSTDs). CSTDs are designed to protect healthcare workers from exposure to dangerous drugs during the preparation and administration of intravenous therapy. CSTDs are becoming increasingly important in cancer therapy, where dangerous drugs are frequently used. Moreover, the use of nanotechnology in IV solutions is another technological breakthrough driving the market globally. Nanotechnology is being used to develop infusion solutions that deliver drugs and nutrients to the body more effectively and efficiently. Technological advances in IV solutions are expected to drive the growth of the market by improving the safety, efficacy, and efficiency of IV therapies.
The high cost of IV solutions is challenging the Intravenous Solutions Market growth. The cost of IV solutions continues to increase and this trend is expected to continue during the forecast period. This cost increase is due to several factors, such as the high cost of raw materials, manufacturing processes, and transportation costs. The high cost of IV solutions hinders the global market in several ways. First, demand for IV solutions is declining as many healthcare providers and patients cannot afford IV solutions due to their high cost. This is especially true in developing countries where access to affordable healthcare is already limited. Furthermore, the high cost of IV solutions has led to lower profitability for IV solution manufacturers and distributors. This is because many healthcare providers are switching to cheaper alternatives such as oral medications and subcutaneous injections to cut costs.
Many cancer patients require IV solutions as part of their treatment, but the high cost of these solutions can place a financial burden on both patients and healthcare providers. Therefore, the high cost of IV solutions is a major challenge for the intravenous Solutions Market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Intravenous IV Solutions Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the intravenous solutions market.
Amanta Healthcare Ltd: The company offers a wide range of IV solutions, including rehydration solutions such as sodium chloride, dextrose, and pre-mixed solutions such as sodium chloride injection, in pack sizes from 100mL to 500mL.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the partial parenteral nutrition segment will be significant during the forecast period. Partial parenteral nutrition (PPN) is a type of IV therapy that provides partial nutritional support to patients who cannot obtain adequate oral nutrition. It is used when the patient's gastrointestinal tract is partially functioning, but oral intake is not sufficient to meet the body's needs. PPN solutions typically contain combinations of glucose, electrolytes, and amino acids in varying ratios based on the patient's specific needs. For example, patients with liver disease may require solutions with low concentrations of amino acids, and patients with renal failure may require solutions with high concentrations of electrolytes.
Get a glance at the market contribution of various segments View the PDF Sample
The partial parenteral nutrition segment was valued at USD 3,735.46 million in 2017 and continued to grow until 2021. Partial parenteral nutrition (PPN) is often used in combination with enteral nutrition (EN). With EN, nutrients are delivered directly to the gastrointestinal tract via a feeding tube. The use of both PPN and EN is called dual nutritional support and is common in critically ill patients. PPN is a type of IV solution used to provide partial nutritional support to patients who cannot obtain adequate nutrients orally. Hence, this segment will contribute to the growth of the market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
Asia is estimated to contribute 33% to the growth of the global intravenous IV solutions market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Asia is projected to be the largest market in 2022 and the forecast period, with Japan, China, Singapore, India, and South Korea being the largest contributors in terms of revenue. The market is driven by rising healthcare costs, the rising prevalence of chronic diseases, and an aging population. The growing focus of key market players on emerging markets, increasing disposable income, the introduction of infusion therapy devices, and the increasing number of clinics and hospitals such as Fortis Healthcare (India) and Singapore General Hospital (Singapore) are also contributing to market growth.
The COVID-19 outbreak had a significant impact on market growth in 2020. The pandemic increased the demand for IV solutions. This enabled intensive care unit (ICU) patients to receive essential medicines and nutrients. In addition, important growth-promoting factors are the increasing prevalence of diabetes, cancer, gastrointestinal disorders, and neurological diseases. In addition, the superior efficacy and shorter response time of IV solution therapy fueled the market expansion in 2020. Additionally, R&D activity also fueled market growth due to the easing of lockdown restrictions and the launch of the COVID-19 vaccine. Some business and industrial activities resumed with appropriate safety and precautionary measures in place, increasing the production of IV solutions. In addition, the increasing prevalence of chronic diseases such as cancer and the increasing geriatric population whose patients need to receive essential nutritional products via intravenous route will drive the growth of the market during the forecast period.
The intravenous IV solutions market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Intravenous IV Solutions Market Scope |
|
Report Coverage |
Details |
Page number |
153 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.11% |
Market growth 2023-2027 |
USD 4011.34 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.68 |
Regional analysis |
Asia, North America, Europe, and Rest of World (ROW) |
Performing market contribution |
Asia at 33% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Group, Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., Vitapure Corp., B. Braun Melsungen AG, and Otsuka Holdings Co. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.